Identifying novel therapeutic agents using xenograft models of pediatric cancer
نویسندگان
چکیده
منابع مشابه
Novel Therapeutic Agents in Pediatric Sepsis - Zinc
Zinc status and infections are closely inter-related. For nearly half a century, the effects that zinc depletion has on the status of the immune system has been slowly elucidated. More recently, the effects that infection and sepsis have on an organism's zinc supplies have begun to be recognized and potential therapeutic intervention in this zinc/infection interplay are beginning to be explored...
متن کاملCharacterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models
Acute megakaryoblastic leukemia (AMKL) is a heterogeneous disease generally associated with poor prognosis. Gene expression profiles indicate the existence of distinct molecular subgroups, and several genetic alterations have been characterized in the past years, including the t(1;22)(p13;q13) and the trisomy 21 associated with GATA1 mutations. However, the majority of patients do not present w...
متن کاملCardiac glycosides as novel cancer therapeutic agents.
The class of steroid-like compounds designated cardiac glycosides includes well-known drugs such as digoxin, digitoxin, and ouabain. Their continued efficacy in treatment of congestive heart failure and as anti-arrhythmic agents is well appreciated. Less well known, however, is the emerging role of this category of compounds in the prevention and/or treatment of proliferative diseases such as c...
متن کاملATP citrate lyase inhibitors as novel cancer therapeutic agents.
ATP citrate lyase (ACL or ACLY) is an extra-mitochondrial enzyme widely distributed in various human and animal tissues. ACL links glucose and lipid metabolism by catalyzing the formation of acetyl-CoA and oxaloacetate from citrate produced by glycolysis in the presence of ATP and CoA. ACL is aberrantly expressed in many immortalized cells and tumors, such as breast, liver, colon, lung and pros...
متن کاملBET inhibitors as novel therapeutic agents in breast cancer
Tumoral cells not only depend on oncogenic abnormalities to maintain its malignant phenotype but on non-oncogenic vulnerabilities. Targeting epigenomics can modify specific cellular functions required for malignant transformation. The Bromodomain (BRD) family mediates their effect by recruiting proteins of the transcription machinery, recognizing acetylated-lysine residues in nucleosomal histon...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Chemotherapy and Pharmacology
سال: 2016
ISSN: 0344-5704,1432-0843
DOI: 10.1007/s00280-016-3042-6